This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Iliakis, G., Pantelias, G. & Kurtzman, S. Mechanism of radiosensitization by halogenated pyrimidines: Effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells. Radiat. Res. 125, 56–64 (1991).
Culver, K.W., Vickers, T.M., Lamsam, J.L., Walling, H.W. & Seregina, T. Gene therapy for solid tumours. Br. med. Bull. 51, 192–204 (1995).
Kim, J.H., Kim, S.H., Brown, S.L. & Freytag, S.O. Selective enhancement of an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res. 54, 6053–6056 (1994).
Fitzgerald, T.J. et al. Activated human N-ras oncogene enhances X-irradiation repair of mammalian cells in vitro less effectively at low dose rate. Am J. clin. Oncol. 8, 517–522 (1985).
McKenna, W.G. et al. Synergistic effect of the v-myc oncogene with H-ras on radioresistance. Cancer Res. 50, 97–102 (1990).
Kasid, U. et al. Effect of antlsense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science 243, 1354–1356 (1989).
Markiewicz, D.A., McKenna, W.G., Flick, M.B., Maity, A. & Muschel, R.J. The effects of radiation on the expression of a newly cloned and characterized rat cyclin B mRNA. Int. J. Radiat. Oncol. Biol. Phys. 28, 135–144 (1994).
Chen, C.H., Zhang, J. & Ling, C.C. Transfected c-myc and c-Ha-ras modulate radiation-induced apoptosis in rat embryo cells. Radiat. Res. 139, 307–315 (1994).
Milas, L., Stephens, L.C. & Mcyn, R.E. Relation of apoptosis to cancer therapy. In Vivo 8, 665–673 (1994).
Kastan, M.B., Canman, C.E. & Leonard, C.J. p53, cell cycle control and apoptosis: Implications for cancer. Cancer Metastasis Rev. 14, 3–15 (1995).
Lane, D.P. et al. On the regulation of the p53 tumour suppressor, and its role in the Cellular response to DNA damage. Phil. Trans. R. Soc. Land. B. Biol. Sci. 347, 83–87 (1995).
Lowe, S.W. et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807–810 (1994).
Tanaka, N. et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77, 829–839 (1994).
Tamura, T. et al. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376, 596–599 (1995).
Miyashita, T. et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799–1805 (1994).
Datta, R. et al. Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ. 6, 363–370 (1995).
Hallahan, D.E., Haimovitz, F.A., Kufe, D.W., Fuks, Z. & Weichselbaum, R.R. The role of cytokines in radiation oncology. in Important Advances in Oncology (eds de Vita, V.T., Hellman, S. & Rosenberg, S.) 71–80 (Lippincott, Philadelphia, 1993).
McBride, W.H. et al. Modification of tumor microenvironment by cytokine gene transfer. Acta Oncol. 34, 447–451 (1995).
Jung, M. et al. Fibroblast growth factor-4 enhanced G2 arrest and Cell survival following ionizing radiation. Cancer Res. 54, 5194–5197 (1994).
Stone, H.B., Brown, J.M., Phillips, T.L. & Sutherland, R.M. Oxygen in human tumors: Correlations between methods of measurement and response to therapy. Summary of a workr shop held 19–20 November 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat. Res. 136, 422–434 (1993).
Milas, L., Wike, J., Hunter, N., Volpe, J. & Basic, I. Macrophage content of murine sarcomas and carcinomas: Associations with tumor growth parameters and tumor radiocurability. Cancer Res. 47, 1069–1075 (1987).
Hallahan, D.E. et al. Spatial and temporal control of gene therapy using ionizing radiation. Nature Med. 1, 786–791 (1995).
Chu, T.H. & Dornburg, R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J. Virol. 69, 2659–2663 (1995).
Russell, S.J., Hawkins, R.E. & Winter, G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 21, 1081–1085 (1993).
Vile, R.G. Tumor-specific gene expression. Semin. Cancer Biol. 5, 429–436 (1994).
Ausserer, W.A., Bourrat, F.B., Green, C.J., Laderoute, K.R. & Sutherland, R.M. Regulation of c-jun expression during hypoxic and low-glucose stress. Molec. Cell. Biol. 14, 5032–5042 (1994).
Weichselbaum, R.R. et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res. 54, 4266–4269 (1994).
Boothman, D.A., Lee, I.W. & Sahijdak, W.M. Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: Potential uses of X-ray-responsive elements for gene therapy. Radiat. Res. 138, S68–71 (1994).
Cheng, X. & Iliakis, G. Effect of ionizing radiation on the expression of chloramphenicol acetyltransferase gene under the control of commonly used constitutive or inducible promoters. Int. J. Radiat. Biol. 67, 261–267 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mcbride, W., Dougherty, G. Radiotherapy for genes that cause cancer. Nat Med 1, 1215–1217 (1995). https://doi.org/10.1038/nm1195-1215
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1195-1215
This article is cited by
-
Development of synthetic promoters for radiation-mediated gene therapy
Gene Therapy (2000)
-
Gene therapy in lung cancer
Current Oncology Reports (2000)